
DeepMind's AlphaGenome Maps How Mutations Drive Disease
Google DeepMind unveils AlphaGenome, an AI that predicts how genetic mutations affect gene regulation across tissues, helping scientists pinpoint disease-driving variants and potentially guide new therapies; trained on public human and mouse data, it analyzes large DNA segments to map essential regulatory elements and their cell-type effects, with early praise from researchers but noting that real-world validation remains ongoing.













